Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Search
About Us
Sign in
Chemical Industry News, Data & Insights
About Us
Sign in
Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Products
WEEKLY
FOCUS
ALPHA
All news
(page 63)
17 February 2026
Huntsman Q4 2025 Earnings Report
Q4 2025 net loss of $96M, adjusted net loss of $63M. Adjusted EBITDA at $35M. Free cash flow from operations at $20M, down from $108M last year.
17 February 2026
Novo Nordisk: EU Approves Higher Wegovy® Dose for Obesity, 21% Average Weight Loss
The EU approved a 7.2 mg Wegovy® dose for obesity. In studies, participants lost 21% body weight on average. Common side effects: nausea, diarrhea, vomiting, and dysaesthesia.
17 February 2026
Genmab Releases 2025 Annual Report
The report highlights 2025 achievements, financials, and 2026 outlook, including revenue growth, strategic acquisitions, and regulatory approvals.
17 February 2026
FDA Approves Johnson & Johnson's Monthly EGFR Therapy RYBREVANT FASPRO
FDA approves monthly dosing for RYBREVANT FASPRO, maintaining efficacy and reducing administration time and reactions compared to bi-weekly and IV schedules for EGFR-mutated NSCLC treatment.
17 February 2026
Fluor 2025 Financial Results Summary
2025 saw $754M in share repurchases, $12B in new awards, and a $25.5B backlog. Revenue hit $15.5B with a $51M net loss. $1.35B received from NuScale share sales in Q1 2026.
17 February 2026
Fluor Sells 71M NuScale Shares for $1.35B, Plans to Trade Remaining 40M
Fluor repurchased 17M shares for $700M and increased its share repurchase program by 30M shares. Further details to be discussed in the upcoming earnings call.
News type
Project Updates and Milestones
New Projects and Expansions
Mergers, Acquisitions, and Partnerships
Innovation and Product Development
Operational Changes and Investments
Sustainability and Environmental Initiatives
Financial Performance and Strategy
Executive Appointments and Governance Changes
Regulatory and Compliance Updates
Workforce and Corporate Social Responsibility (CSR)
Crisis and Risk Management
The right choices in the European chemical industry
Save time with
chemXplore Alpha
Learn more
17 February 2026
ElevenEs Secures Series B Funding with Caterpillar Venture Capital
ElevenEs to start building a 1GWh LFP battery factory in Serbia, aiming for 2027 deliveries, creating 350 jobs, and advancing European battery tech.
17 February 2026
Kemira to Build Activated Carbon Reactivation Plant in Spain
Kemira plans a EUR 20M plant in Tarragona to boost activated carbon reactivation for water treatment, aiming to meet rising demand and support regulatory compliance by 2029.
17 February 2026
Stahl Wins 2025 adiFORMULATOR Award from adidas
Stahl's commitment to safer formulations and ZDHC compliance earns recognition, highlighting its role in advancing sustainable practices in the chemical industry.
17 February 2026
Roche Appoints Mark Dawson to Executive Committee
Mark Dawson becomes Head of Pharma Research and Early Development, joining from Peter MacCallum Cancer Centre, effective May 2026.
17 February 2026
Neste and World Fuel Services Expand SAF Availability at 100+ European Airports
The five-year agreement supports regulatory compliance and boosts SAF supply, leveraging World Fuel's network and Neste's production capabilities.
17 February 2026
ORLEN's Largest Investment Program
PLN 380 billion will modernize Poland's energy system, focusing on gas security, renewables, and grid expansion, ensuring secure, affordable energy.
17 February 2026
OMV Petrom Modernizes Waste-Water Systems at Petrobrazi Refinery
Invested 20 million euros in advanced waste-water treatment, part of a broader modernization effort exceeding 2 billion euros since 2005, including a new sustainable fuels project.
17 February 2026
Worley Advises on New Zealand LNG Terminal
Worley provides technical support for New Zealand's LNG terminal, ensuring international standards and local compliance, from procurement to commissioning.
17 February 2026
Alchemedicine and Asahi Kasei Pharma License Agreement for HiSAP Compounds
Asahi Kasei Pharma gains global rights to develop and commercialize HiSAP compounds, with Alchemedicine receiving up to ¥41.3 billion in payments and royalties.
16 February 2026
Kao selected by NEDO to build saccharification enzyme supply platform
Selected by NEDO to build a saccharification enzyme supply platform to convert unused biomass into sugars for bioproducts including bioethanol and SAF.
16 February 2026
Boehringer Ingelheim Earns EcoVadis Gold for Sustainability
Ranked in the top 5% by EcoVadis, the company excels in Environment, Labor & Human Rights, Ethics, and Sustainable Procurement, reflecting strong ESG practices and continuous improvement.
16 February 2026
Horse Powertrain and Repsol Develop Efficient Hybrid Powertrain with Renewable Gasoline
The new hybrid powertrain achieves 44.2% efficiency, cuts fuel use by 40%, and reduces CO2 emissions using 100% renewable gasoline, supporting a technology-neutral approach to decarbonization.
16 February 2026
MOL Requests Release of Strategic Oil Reserves to Ensure Supply
No oil via Druzhba since Jan 2026. MOL shifts to seaborne supply, first arrivals in March. Hungary may release 250,000 tons of reserves. 90-day reserves secure supply. Monitoring continues.
16 February 2026
Geoinform Ltd. and Baker Hughes Form Strategic Partnership
The partnership aims to enhance operational efficiency with innovative technologies, covering services, asset maintenance, and professional training in the energy sector.
16 February 2026
MOL Requests Release of Strategic Oil Reserves to Ensure Supply
Due to halted Druzhba pipeline deliveries, seaborne crude oil is being used. Strategic reserves may be tapped if eastern shipments don't resume. Fuel supply remains stable.
16 February 2026
Moeve and ADA Form Quantum Computing Alliance
The alliance aims to boost quantum tech in Andalusia, enhancing energy efficiency and security, with IBM as a tech partner and Ayesa collaborating.
16 February 2026
Lilly's Retevmo Shows Event-Free Survival Benefit in Early-Stage RET Fusion-Positive Lung Cancer
Selpercatinib significantly reduces disease recurrence risk in early-stage RET fusion-positive NSCLC. Safety profile aligns with previous trials. Detailed results pending.
16 February 2026
Eni Discovers Gas and Condensate in Côte d'Ivoire's Calao Channel
Murene South-1X well in Block CI-501 confirms significant gas and condensate potential in Côte d'Ivoire, with estimated volumes of 5.0 Tcf gas and 450 million barrels of condensate.
16 February 2026
Chevron Secures Four Offshore Leases for Greek Exploration
Chevron and HELLENiQ ENERGY sign agreements for offshore exploration in Greece, focusing on seismic work to assess hydrocarbon potential. Awaiting Greek Parliament ratification.
16 February 2026
BASF Boosts BDO Production in Ludwigshafen for European Supply Security
Increased BDO output supports stable supply and strengthens downstream markets, focusing on sustainability and long-term European partnerships.
16 February 2026
SPIE Joins IPAI to Boost AI Expertise
SPIE joins IPAI to enhance AI capabilities, focusing on practical solutions in energy and communications, while promoting human-centered AI and collaboration.
16 February 2026
UBE Invests in Immaterial Ltd
Investment supports commercialization of CO₂ capture tech using Metal-Organic Frameworks, aiming to reduce industrial decarbonization costs and meet global demand for sustainable solutions.
16 February 2026
Roche Reports Positive Phase III Results for Gazyva in Membranous Nephropathy
Phase III study shows Gazyva achieves higher remission rates in membranous nephropathy, with safety consistent and no new signals. Data to be shared with health authorities.
15 February 2026
AFC Energy and Komatsu Collaborate on Ammonia-Fueled Engine Development
The JDA aims to integrate ammonia cracking tech with diesel engines, offering a sustainable solution for construction and mining equipment, with a contract value of around $2 million.
← Previous
Next →